4-nitroquinoline-1-oxide has been researched along with Angiogenesis, Pathologic in 4 studies
4-nitroquinoline N-oxide : A quinoline N-oxide carrying a nitro substituent at position 4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral squamous cell carcinoma (OSCC) remains as one of the most difficult malignancies to control because of its high propensity for local invasion and cervical lymph node dissemination." | 1.40 | Novel DOX-MTX nanoparticles improve oral SCC clinical outcome by down regulation of lymph dissemination factor VEGF-C expression in vivo: oral and IV modalities. ( Abbasi, MM; Hamishehkar, H; Jahanban- Esfahlan, R; Monfaredan, A; Seidi, K, 2014) |
| "The sequencing of the head and neck cancer has provided a blueprint of the most frequent genetic alterations in this cancer type." | 1.39 | PTEN deficiency contributes to the development and progression of head and neck cancer. ( Abrahao, AC; Castilho, RM; Gutkind, JS; Lingen, MW; Molinolo, A; Squarize, CH, 2013) |
| " We determined that 8 weeks of 100 microg/mL 4-NQO in the drinking water was the optimal dosage and duration to cause a sufficient incidence of hyperkeratoses, dysplasias, and HNSCC over a period of 32 weeks with minimal morbidity and mortality." | 1.35 | ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis. ( Hasina, R; Jalil, A; Jones, CL; Kasza, K; Lingen, MW; Martin, LE, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Squarize, CH | 1 |
| Castilho, RM | 1 |
| Abrahao, AC | 1 |
| Molinolo, A | 1 |
| Lingen, MW | 3 |
| Gutkind, JS | 1 |
| Abbasi, MM | 1 |
| Monfaredan, A | 1 |
| Hamishehkar, H | 1 |
| Seidi, K | 1 |
| Jahanban- Esfahlan, R | 1 |
| Hasina, R | 2 |
| Martin, LE | 1 |
| Kasza, K | 1 |
| Jones, CL | 1 |
| Jalil, A | 1 |
| Zhou, G | 1 |
| Wroblewski, K | 1 |
| Mankame, TP | 1 |
| Doçi, CL | 1 |
4 other studies available for 4-nitroquinoline-1-oxide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
PTEN deficiency contributes to the development and progression of head and neck cancer.
Topics: 4-Nitroquinoline-1-oxide; Animals; Carcinogenesis; Carcinoma, Squamous Cell; Cells, Cultured; Cycloo | 2013 |
Novel DOX-MTX nanoparticles improve oral SCC clinical outcome by down regulation of lymph dissemination factor VEGF-C expression in vivo: oral and IV modalities.
Topics: 4-Nitroquinoline-1-oxide; Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protoc | 2014 |
ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis.
Topics: 4-Nitroquinoline-1-oxide; Angiogenesis Inhibitors; Animals; Carcinogens; Carcinoma, Squamous Cell; D | 2009 |
Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Carcinogens; Disease Models, Animal; Drug | 2010 |